Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • Leadership
    • Team
    • Publications
    • Careers
  • Diseases/Disorders
    • One Brain
    • ALS
    • Alzheimer’s
    • Autism
    • Brain Cancer
    • Brain Injury
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • Other
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
  • Ways To Give
    • Giving to Research
    • How You Can Help
    • Events

Funded Grants

Back to results

Regulation of endosomal membrane trafficking by C9ORF72 in ALS

Project Overview

Dr. Peter McPherson, professor at the Montreal Neurological Institute, McGill University will receive one year of support to work on the connection between the most prominent known cause of ALS, a mutation in a gene called C9ORF72, and a previously unrelated critical cellular function called endosomal membrane trafficking. Endosomal membrane trafficking is a cellular process used to transfer substances to and from the surface of cells, as well as inside and out of cells. One of the earliest discoveries about C9ORF72 protein is that it contains something called a DENN domain, which is a structure first identified in the McPherson lab as important in endosomal membrane trafficking. Preliminary studies by Dr. McPherson have shown that C9ORF72 can interact with a prominent trafficking substance called Rab9 and in this project he will further pursue a role for C9ORF72 in the process, including in motor neurons created from induced pluripotent stem cells derived from people living with ALS. Dr. McPherson was also awarded a one year Bridge Grant for this study in September, which represents a small portion of the funds requested by CIHR to complete the project. In light of the selection of this work for its novelty and forward thinking by the ALS Canada-Brain Canada International Peer Review Panel, this Discovery Grant was awarded to provide additional support towards that initial goal.

Principal Investigator

Peter McPherson , McGill University

Partners and Donors

ALS Society of Canada

Project Ongoing

Regulation of endosomal membrane trafficking by C9ORF72 in ALS

  • Program Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Canada - Brain Canada Discovery Grants

  • Province

    Québec

  • Start Date

    2016

  • Total Grant Amount

    $100,000

  • Health Canada Contribution

    $50,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2023 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co